Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Complications

High prevalence of diarrhea but infrequency of documented Clostridium difficile in autologous peripheral blood progenitor cell transplant recipients

Abstract

Autologous peripheral blood progenitor cell (PBPC) transplant recipients frequently receive multiple antibiotics for neutropenic fever in addition to high-dose chemotherapy. Although there are many possible causes for diarrhea in this population, empiric therapy for possible C. difficile colitis is common in some centers. This study sought to define the frequency of diarrhea and of a positive C. difficile toxin assay in PBPC transplant recipients. Data were collected on 80 patients enrolled in a randomized trial of two different antibiotic regimens during PBPC transplant. Data included the presence or absence of diarrhea, all microbiologic studies performed during the transplant admission, and all antimicrobials administered during the transplant admission. Of 80 patients enrolled, 61 (76.3%) developed diarrhea. Only 3/61 (4.9%) had a positive C. difficile toxin assay. A total of 122 C. difficile toxin assays were performed; for each positive C. difficile assay, 41 stool samples were analyzed. Twenty courses of oral metronidazole (18/20 empiric) and 10 courses of oral vancomycin (8/10 empiric) were given. A total of 25 of 61 patients with diarrhea (41%) received therapy for possible C. difficile. Diarrhea is common during autologous PBPC transplant but a positive C. difficile assay is uncommon. The practice of empiric therapy for C. difficile in this population in a non-outbreak setting should be re-evaluated. Bone Marrow Transplantation (2000) 25, 67–69.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Bartlett JG . Clostridium difficile: clinical considerations Rev Infect Dis 1990 12: (Suppl. 2) S243–S251

    Article  Google Scholar 

  2. McFarland LV, Mulligan ME, Kwok RYY, Stamm WE . Nosocomial acquisition of Clostridium difficile infection New Engl J Med 1989 320: 204–210

    Article  CAS  Google Scholar 

  3. Kelly CP, Pothoulakis C, LaMont JT . Clostridium difficile colitis New Engl J Med 1994 330: 257–262

    Article  CAS  Google Scholar 

  4. Nath SK, Thornley JH, Kelly M et al. A sustained outbreak of Clostridium difficile in a general hospital: persistence of a toxigenic clone in four units Infect Control Hosp Epidemiol 1994 15: 382–389

    Article  CAS  Google Scholar 

  5. Fekety R . Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis Am J Gastroenterol 1997 92: 739–750

    CAS  PubMed  Google Scholar 

  6. Johnson S, Gerding DN . Clostridium difficile-associated diarrhea Clin Infect Dis 1998 26: 1027–1036

    Article  CAS  Google Scholar 

  7. Grundfest-Broniatowski S, Quader M, Alexander F et al. Clostridium difficile colitis in the critically ill Dis Colon Rectum 1996 39: 619–623

    Article  CAS  Google Scholar 

  8. Centers for Disease Control and Prevention. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR 44 (RR-12) 1995 1–13

  9. Anglin AM, Klym B, Byers KE et al. Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant Enterococcus faecium Arch Intern Med 1997 157: 1132–1136

    Article  Google Scholar 

  10. Gerding DN . Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infection? Clin Infect Dis 1997 25: (Suppl. 2) S206–S210

    Article  Google Scholar 

  11. Bilgrami S, Feingold JM, Dorsky D et al. Incidence and outcome of Clostridium difficile infection following autologous peripheral blood stem cell transplantation Bone Marrow Transplant 1999 23: 1039–1042

    Article  CAS  Google Scholar 

  12. Kavan P, Sochor M, Nyc O et al. Pseudomembraneous clostridium after autologous bone marrow transplantation Bone Marrow Transplant 1998 21: 521–523

    Article  CAS  Google Scholar 

  13. Cox GJ, Matsui SM, Lo RS et al. Etiology and outcome of diarrhea after marrow transplantation: a prospective study Gastroenterology 1994 107: 1398–1407

    Article  CAS  Google Scholar 

  14. Yolken RH, Bishop CA, Townsend TR et al. Infectious gastroenteritis in bone-marrow-transplant recipients New Engl J Med 1982 306: 1010–1012

    Article  CAS  Google Scholar 

  15. Blakey JL, Barnes GL, Bishop RF, Ekert H . Infectious diarrhea in children undergoing bone-marrow transplantation Aust NZ J Med 1989 19: 31–36

    Article  CAS  Google Scholar 

  16. Aplin MS, Weiner R, Graham Pole J et al. Enterocolitis in allogeneic marrow transplant patients (abstract) Exp Hematol 1990 18: 696

    Google Scholar 

  17. Avery R, Pohlman B, Longworth D et al . A randomized prospective trial of single daily dose vancomycin and tobramycin plus oral ciprofloxacin versus standard triple antibiotics in febrile neutropenic recipients of autologous progenitor cell transplants. 15th Annual Meeting, American Society of Transplant Physicians, Chicago, May 1997, Abstr. No. 530

  18. Knapp CC, Sandin RL, Hall GS et al. Comparison of Vidas Clostridium difficile toxin-A assay to cytotoxin-B tissue culture assay for the detection of toxins of C. difficile Diagn Microbiol Infect Dis 1993 17: 7–12

    Article  CAS  Google Scholar 

  19. Lucas GM, Lechtzin N, Puryear DW et al. Vancomycin-resistant and vancomycin-suspectible enterococcal bacteremia: comparison of clinical features and outcomes Clin Infect Dis 1998 26: 1127–1133

    Article  CAS  Google Scholar 

  20. Mossad SB, Longworth DL, Goormastic M et al. Early infectious complications in autologous bone marrow transplantation: a review of 219 patients Bone Marrow Transplant 1996 18: 265–271

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Avery, R., Pohlman, B., Adal, K. et al. High prevalence of diarrhea but infrequency of documented Clostridium difficile in autologous peripheral blood progenitor cell transplant recipients. Bone Marrow Transplant 25, 67–69 (2000). https://doi.org/10.1038/sj.bmt.1702086

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702086

Keywords

This article is cited by

Search

Quick links